Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Markets

Zydus receives Mexican regulatory approval for cancer drug - Bhava

Zydus Lifesciencesannounced that the Mexican regulatory authority COFEPRIS (Federal Commission for the Protection Against Sanitary Risk), has granted marketing approval for Bhava™, a Bevacizumab biosimilar.

By: business-standard.com

Jul 22 2024
0
0 Views

Zydus receives Mexican regulatory approval for cancer drug - Bhava

Zydus receives Mexican regulatory approval for cancer drug - Bhava

Related

Zydus receives Mexican regulatory approval for cancer drug - Bhava

Fineotex Chemical raises Rs 342.5 cr via preferential allotment of shares and warrants

JSW Neo Energy receives LoA for 300 MW solar power project

JSW Neo Energy wins LoA for 500 MW solar power project and 250 MW energy storage system

Nomura picks BPCL as top OMC stock on attractive valuation; sees 21% upside

Emami Ltd Spikes 4.69%

Reliance Industries Ltd Slides 2.78%, BSE Energy index Shed 1.43%

Yes Bank gains as Q1 PAT climbs 47% YoY to Rs 502 crore

Vedanta declared preferred bidder for composite license of critical mineral blocks

HG Infra up on receiving letter from East Central Railway for Bihar project

Power shares gain

Utilties shares gain

Fineotex Chemical raises Rs 342.5 cr via preferential allotment of shares and warrants